Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 1;36(3):360-366.
doi: 10.1097/HCO.0000000000000847.

Racial disparities in Coronavirus Disease 2019 (COVID-19) outcomes

Affiliations
Review

Racial disparities in Coronavirus Disease 2019 (COVID-19) outcomes

Yeabsra Kefyalew Aleligne et al. Curr Opin Cardiol. .

Abstract

Purpose of review: The Coronavirus Disease 2019 (COVID-19) pandemic has exposed preexisting racial disparities in the healthcare system. This review discusses racial-ethnic differences in COVID-19 related outcomes with an emphasis on the social determinants of health that are responsible for these disparities.

Recent findings: Higher hospitalizations and deaths have been reported amongst minority individuals after a COVID-19 infection. Cardiovascular disease and its risk factors are also more common in minority populations and negatively impact clinical outcomes after a COVID-19 illness. The racial disparities seen after COVID-19 infections appear to be driven by multiple preexisting comorbidities, adverse socioeconomic conditions, and lack of access to healthcare. These disadvantages were present before the COVID-19 pandemic. To effectively reduce disparities in outcomes of COVID-19 and the impact of the virus on minority communities, a multifaceted approach will be needed.

Summary: Government-backed policies that foster health equity and promote easily accessible testing and fair distribution of COVID-19 therapies and vaccines are necessary to successfully combat racial disparities in COVID-19 outcomes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. WHO coronavirus disease (COVID-19) dashboard. Geneva: World Health Organization, 2020. Available at: https://covid19.who.int/ . [Accessed 27 December 2020]
    1. Johns Hopkins Coronavirus Resource Center. Johns Hopkins University & Medicine. Available at: https://coronavirus.jhu.edu/data/mortality . [Accessed 27 December 2020]
    1. Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020; 382:2372–2374.
    1. Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One 2020; 15:e0234765 https://doi.org/10.1371/journal.pone.0234765 - DOI
    1. Kopel J, Perisetti A, Roghani A, et al. Racial and gender-based differences in COVID-19. Front Public Heal 2020; 8:418 https://doi.org/10.3389/fpubh.2020.00418 - DOI